Patrick R. O'neil - Net Worth and Insider Trading

Patrick R. O'neil Net Worth

The estimated net worth of Patrick R. O'neil is at least $2 Million dollars as of 2025-07-02. Patrick R. O'neil is the EVP CLO & General Counsel of Ionis Pharmaceuticals Inc and owns about 56,245 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $2 Million. Details can be seen in Patrick R. O'neil's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick R. O'neil has not made any transactions after 2025-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Patrick R. O'neil

Patrick R. O'neil Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick R. O'neil owns 1 companies in total, including Ionis Pharmaceuticals Inc (IONS) .

Click here to see the complete history of Patrick R. O'neil’s form 4 insider trades.

Insider Ownership Summary of Patrick R. O'neil

Ticker	Company	Transaction Date	Type of Owner
IONS	Ionis Pharmaceuticals Inc	2025-02-20	SVP & Legal and General Counsel

Patrick R. O'neil Latest Holdings Summary

Patrick R. O'neil currently owns a total of 1 stock. Patrick R. O'neil owns 56,245 shares of Ionis Pharmaceuticals Inc (IONS) as of February 20, 2025, with a value of $2 Million.

Latest Holdings of Patrick R. O'neil

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
IONS	Ionis Pharmaceuticals Inc	2025-02-20	56,245	43.59	2,451,720

Holding Weightings of Patrick R. O'neil

Patrick R. O'neil Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick R. O'neil has made a total of 15 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 1,207 shares on February 20, 2025, which brought Patrick R. O'neil around $39,046.

Insider Trading History of Patrick R. O'neil

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick R. O'neil Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick R. O'neil Ownership Network

Ownership Network List of Patrick R. O'neil

No Data

Ownership Network Relation of Patrick R. O'neil

Patrick R. O'neil Owned Company Details

What does Ionis Pharmaceuticals Inc do?

Who are the key executives at Ionis Pharmaceuticals Inc?

Patrick R. O'neil is the SVP & Legal and General Counsel of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include EVP & Corp and Development Ops Brian Birchler , Chief Business Officer Joseph Baroldi , and director & Senior Vice President Brett P Monia .

Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary

Over the past 18 months, Patrick R. O'neil made 8 insider transaction in Ionis Pharmaceuticals Inc (IONS) with a net sale of 34,288. Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 198,346 shares made by Brett P Monia , a net sale of 30,715 shares made by Eric Swayze , and a net sale of 22,853 shares made by Richard S Geary .

In summary, during the past 3 months, insiders sold 7,624 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 15,000 shares, with a net purchase of 7,376 shares. During the past 18 months, 445,942 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 425,942 shares.

Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ionis Pharmaceuticals Inc Insider Transactions

No Available Data

Patrick R. O'neil Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick R. O'neil. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Patrick R. O'neil's mailing address is: Carlsbad Ca 92010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.